Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Currency in USD	2025
Operating Income	68.20 Million
Income Before Tax	22.00 Million
Income Tax Expense	29.30 Million
Net Income	-8.6 Million
Eps	-0.15
Epsdiluted	-0.15
Weighted Average Shs Out	151.80 Million
Weighted Average Shs Out Dil	151.80 Million
Research And Development Expenses	395.20 Million
Selling General And Administrative Expenses	946.50 Million
Depreciation And Amortization	220.30 Million
Interest Expense	60.30 Million
Interest Income	14.80 Million
Net Interest Income	-46.7 Million
Premiums Earned	N/A
Policyholder Benefits	N/A
Gross Profit	1.58 Billion
Ebitda	288.50 Million
Source	edgar
Ebit	82.30 Million

Bruker Corporation Annual Reports (10-K)